{"id":1395,"date":"2026-08-26T16:25:14","date_gmt":"2026-08-26T13:25:14","guid":{"rendered":"https:\/\/life-peptide.com\/?page_id=1395"},"modified":"2026-08-26T16:25:17","modified_gmt":"2026-08-26T13:25:17","slug":"glow-peptide-blend-ghk-cu-bpc-157-and-tb-500-research","status":"publish","type":"page","link":"https:\/\/life-peptide.com\/fr\/glow-peptide-blend-ghk-cu-bpc-157-and-tb-500-research\/","title":{"rendered":"GLOW peptide blend: GHK-Cu, BPC-157 and TB-500 research"},"content":{"rendered":"<h1 class=\"wp-block-heading\">GLOW Peptide Blend: GHK-Cu, BPC-157 and TB-500 Research<\/h1>\n\n\n\n<p class=\"wp-block-paragraph\">La <strong>GLOW peptide blend<\/strong> combines three distinct research compounds: <strong><a href=\"https:\/\/life-peptide.com\/fr\/product\/ghk-cu-50-mg\/\" data-type=\"product\" data-id=\"337\">GHK-Cu<\/a>, <a href=\"https:\/\/life-peptide.com\/fr\/product\/bpc-157-5-mg\/\" data-type=\"product\" data-id=\"321\">BPC-157<\/a> et <a href=\"https:\/\/life-peptide.com\/fr\/product\/thymosin-%ce%b24-1-43-full-sequence-5-mg\/\" data-type=\"product\" data-id=\"874\">TB-500 (Thymosine \u03b24)<\/a><\/strong>. Each has been investigated separately in connection with tissue remodelling, cellular migration, extracellular-matrix biology and experimental repair processes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The name \u201cGLOW\u201d is a convenient commercial description rather than the name of a single molecule or an established clinical treatment. It usually refers to a combined lyophilised formulation containing substantially more GHK-Cu than either BPC-157 or TB-500.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although the three components overlap in some research areas, they are not interchangeable. Each interacts with different biological mechanisms:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>GHK-Cu<\/strong> is primarily associated with copper-dependent signalling, collagen synthesis and extracellular-matrix remodelling.<\/li>\n\n\n\n<li><strong>BPC-157<\/strong> has mainly been studied in experimental models of tissue protection, angiogenesis and tendon, muscle and gastrointestinal repair.<\/li>\n\n\n\n<li><strong>TB-500\/Thymosin \u03b24<\/strong> is associated with actin regulation, cellular migration, angiogenesis and wound-repair biology.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This distinction helps explain why researchers may examine the compounds together. However, it is equally important to recognise that the scientific literature relates predominantly to the <strong>individual components<\/strong>, not to the complete GLOW blend.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">What is in the GLOW peptide blend?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A commonly available research formulation contains:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Amount<\/th><th>Principal research area<\/th><\/tr><\/thead><tbody><tr><td><a href=\"https:\/\/life-peptide.com\/fr\/product\/ghk-cu-50-mg\/\" data-type=\"product\" data-id=\"337\">GHK-Cu<\/a><\/td><td>50 mg<\/td><td>Collagen and extracellular-matrix remodelling<\/td><\/tr><tr><td><a href=\"https:\/\/life-peptide.com\/fr\/product\/bpc-157-5-mg\/\" data-type=\"product\" data-id=\"321\">BPC-157<\/a><\/td><td>10 mg<\/td><td>Experimental tissue protection and repair<\/td><\/tr><tr><td><a href=\"https:\/\/life-peptide.com\/fr\/product\/thymosin-%ce%b24-1-43-full-sequence-5-mg\/\" data-type=\"product\" data-id=\"874\">TB-500 \/ Thymosine \u03b24<\/a><\/td><td>10 mg<\/td><td>Actin regulation and cellular migration<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The different quantities should not be interpreted as equivalent biological doses. GHK-Cu, BPC-157 and Thymosin \u03b24 are structurally different molecules with different molecular weights, mechanisms and experimental concentrations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A combined vial offers a fixed ratio for laboratory work. Separate compounds remain more appropriate when a study requires independent concentrations, individual controls or isolation of the effects of a single molecule.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">GHK-Cu: copper signalling and tissue remodelling<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">GHK is a naturally occurring tripeptide composed of glycine, histidine and lysine. It binds copper ions to form the complex commonly written as <strong>GHK-Cu<\/strong> ou <strong>Cu-GHK<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Copper is involved in several biological processes relevant to connective tissue and extracellular-matrix organisation. Research involving GHK-Cu has examined:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>collagen production;<\/li>\n\n\n\n<li>fibroblast activity;<\/li>\n\n\n\n<li>extracellular-matrix remodelling;<\/li>\n\n\n\n<li>antioxidant and inflammatory signalling;<\/li>\n\n\n\n<li>angiogenesis;<\/li>\n\n\n\n<li>tissue-repair responses.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">An early laboratory study found that GHK-Cu stimulated collagen synthesis in fibroblast cultures. Subsequent research explored broader effects on tissue remodelling and gene expression. These findings helped establish GHK-Cu as one of the most extensively investigated copper-binding peptides in skin and repair research.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GHK-Cu is often associated with cosmetic products, but its research context is broader than appearance alone. Collagen formation, fibroblast behaviour and extracellular-matrix regulation are fundamental processes in many types of tissue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The strength of the evidence nevertheless depends on the application. GHK-Cu has substantial laboratory and topical research behind it, but results from one formulation or route cannot automatically be transferred to every other experimental format.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18644225\/\" target=\"_blank\" rel=\"noopener\">Read the GHK and tissue-remodelling review<\/a><br><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/3169264\/\" target=\"_blank\" rel=\"noopener\">View the fibroblast collagen-synthesis study<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">BPC-157: experimental tissue-protection research<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">BPC-157 is a synthetic peptide containing 15 amino acids. It has been studied principally in cell cultures and animal models involving:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>tendon and muscle repair;<\/li>\n\n\n\n<li>fibroblast migration;<\/li>\n\n\n\n<li>collagen organisation;<\/li>\n\n\n\n<li>gastrointestinal tissue;<\/li>\n\n\n\n<li>vascular responses and VEGF signalling;<\/li>\n\n\n\n<li>experimental inflammatory processes.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In an animal study of injured muscle and tendon, researchers reported changes in VEGF expression and angiogenesis during the healing process. Importantly, the same paper did not find a direct angiogenic effect in its cell-culture model. That distinction illustrates why BPC-157 should not simply be described as an \u201cangiogenesis peptide\u201d: its reported effects appear to depend on the biological model and surrounding repair process.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Another experimental study found that BPC-157 promoted tendon-fibroblast outgrowth and migration. These results are interesting for mechanistic research, but they do not establish clinical efficacy in people.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Human evidence remains extremely limited. Small observational and pilot reports exist, but they are not comparable to large, controlled clinical trials. BPC-157 should therefore be understood as an <strong>experimental research compound<\/strong>, not as a clinically validated therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20388964\/\" target=\"_blank\" rel=\"noopener\">View the muscle and tendon angiogenesis study<\/a><br><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\" target=\"_blank\" rel=\"noopener\">View the tendon-fibroblast study<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">TB-500 and Thymosin \u03b24: actin and cellular migration<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Thymosin \u03b24 is a naturally occurring 43-amino-acid peptide found in many tissues and cell types. One of its best-characterised functions is its interaction with <strong>actin<\/strong>, a structural protein involved in cell shape, movement and organisation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cell migration is an essential part of experimental repair biology. Endothelial cells, keratinocytes and other cell types must move and reorganise as tissue structures change. Research involving Thymosin \u03b24 has therefore examined:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>actin sequestration and cytoskeletal regulation;<\/li>\n\n\n\n<li>endothelial-cell migration;<\/li>\n\n\n\n<li>keratinocyte migration;<\/li>\n\n\n\n<li>blood-vessel formation;<\/li>\n\n\n\n<li>inflammatory signalling;<\/li>\n\n\n\n<li>collagen deposition;<\/li>\n\n\n\n<li>dermal, corneal and cardiac repair models.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In animal wound models, Thymosin \u03b24 accelerated several measures associated with dermal repair, including wound contraction and collagen deposition. Other laboratory work connected its actin-binding region with endothelial-cell migration and angiogenic activity.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The term <strong>TB-500<\/strong> is widely used in the research-peptide market for Thymosin \u03b24-related material. Because naming practices can vary between suppliers, researchers should verify the precise sequence and identity stated in the product documentation rather than relying exclusively on the commercial name.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12581423\/\" target=\"_blank\" rel=\"noopener\">View the Thymosin \u03b24 dermal-repair study<\/a><br><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\">View the actin-binding and cellular-migration study<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Pourquoi associe-t-on le GHK-Cu, le BPC-157 et le TB-500 ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The rationale for the GLOW blend is based on the <strong>different but partially overlapping mechanisms<\/strong> reported for its components.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Research process<\/th><th>GHK-Cu<\/th><th>BPC-157<\/th><th>Thymosine \u03b24<\/th><\/tr><\/thead><tbody><tr><td>Collagen and matrix remodelling<\/td><td>Strong research focus<\/td><td>Studied experimentally<\/td><td>Observed in repair models<\/td><\/tr><tr><td>Fibroblast activity<\/td><td>Oui<\/td><td>Oui<\/td><td>Indirect involvement<\/td><\/tr><tr><td>Cellular migration<\/td><td>Studied<\/td><td>Studied<\/td><td>Major research focus<\/td><\/tr><tr><td>Angiogenic signalling<\/td><td>Studied<\/td><td>Model-dependent<\/td><td>Studied<\/td><\/tr><tr><td>Actin regulation<\/td><td>Not primary<\/td><td>Not primary<\/td><td>Major research focus<\/td><\/tr><tr><td>Human evidence<\/td><td>Limited and application-dependent<\/td><td>Very limited<\/td><td>Limited and formulation-dependent<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">This produces a plausible <strong>multi-pathway research hypothesis<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>GHK-Cu provides a copper-binding signal associated with collagen and matrix biology.<\/li>\n\n\n\n<li>BPC-157 is investigated for tissue-protective and vascular responses in experimental injury models.<\/li>\n\n\n\n<li>Thymosin \u03b24 provides a separate connection to actin regulation and cellular migration.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">However, mechanistic complementarity does not prove synergy. Three compounds affecting related processes do not necessarily produce a stronger, safer or more predictable result when combined.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Has the complete GLOW blend been clinically studied?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">At present, the evidence should be divided into three levels:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Research on the individual molecules<\/strong><br>This represents nearly all of the available literature.<\/li>\n\n\n\n<li><strong>Theoretical or mechanistic rationale for combining them<\/strong><br>Their distinct research pathways explain why a combined formulation is of interest.<\/li>\n\n\n\n<li><strong>Direct evidence for the complete GLOW blend<\/strong><br>Robust, peer-reviewed clinical evidence for the fixed GHK-Cu\/BPC-157\/TB-500 combination has not been established.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">There are no grounds for treating the GLOW name itself as a clinically validated formulation. Claims made about the complete blend are frequently extrapolated from separate studies of its ingredients.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is why responsible interpretation must avoid statements such as \u201cthe combination is proven to accelerate healing\u201d or \u201cthe three peptides work synergistically.\u201d Those conclusions would require controlled studies comparing the blend with its individual components and with suitable controls.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">GLOW blend versus separate research peptides<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A combined vial and separate compounds serve different experimental purposes.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Potential advantages of a combined formulation<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>one defined, repeatable component ratio;<\/li>\n\n\n\n<li>simplified preparation for studies designed around that ratio;<\/li>\n\n\n\n<li>reduced variability from handling three separate containers;<\/li>\n\n\n\n<li>convenient investigation of multi-compound samples.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Limitations of a combined formulation<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the concentration of each component cannot be adjusted independently;<\/li>\n\n\n\n<li>individual control groups still require separate compounds;<\/li>\n\n\n\n<li>results cannot easily be attributed to one component;<\/li>\n\n\n\n<li>chemical compatibility and stability must be evaluated for the complete mixture;<\/li>\n\n\n\n<li>evidence for the individual compounds does not automatically validate the blend.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Researchers conducting mechanistic or concentration-response work will generally need the separate compounds. A fixed blend is more applicable when the combined formulation itself is the object of investigation.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">What should researchers verify when comparing GLOW products?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cGLOW\u201d is not a universally standardised scientific formulation. Products using the same name may contain different quantities or even differently identified Thymosin \u03b24-related material.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Relevant checks include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the amount of each component;<\/li>\n\n\n\n<li>stated peptide sequence and molecular identity;<\/li>\n\n\n\n<li>whether the Thymosin component is full-sequence Thymosin \u03b24;<\/li>\n\n\n\n<li>analytical purity;<\/li>\n\n\n\n<li>identity verification;<\/li>\n\n\n\n<li>batch-specific certificate of analysis;<\/li>\n\n\n\n<li>lyophilised storage conditions;<\/li>\n\n\n\n<li>whether testing covers the finished blend or only its raw ingredients.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A purity percentage alone does not confirm that all three compounds are present in the stated quantities. Identity and quantitative testing are separate analytical questions.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">GLOW peptide blend: the evidence in perspective<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The GLOW peptide blend brings together three compounds connected with different areas of experimental repair biology.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GHK-Cu has the clearest association with copper signalling, collagen and extracellular-matrix remodelling. BPC-157 is supported predominantly by animal and laboratory research involving tissue protection, vascular responses and tendon, muscle and gastrointestinal models. Thymosin \u03b24 has a well-described role in actin regulation and has been examined in cellular-migration and wound-repair studies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The combination is scientifically interesting because these mechanisms are different yet interconnected. But the complete GLOW formulation remains a <strong>research hypothesis assembled from evidence on its individual components<\/strong>. It should not be presented as a clinically proven treatment or as evidence of established synergy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For laboratory work, the important questions are therefore not only what the blend contains, but whether its fixed ratio, analytical documentation and evidence level are appropriate for the intended experimental design.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Explore the GLOW research blend<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">View the complete product specification, batch documentation and laboratory-use information on the <strong><a href=\"https:\/\/life-peptide.com\/fr\/product\/glow-ghk-cu-50-mg-bpc-157-10-mg-and-tb-500-10-mg\/\" data-type=\"product\" data-id=\"394\">GLOW research blend product page<\/a><\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">R\u00e9f\u00e9rences<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Pickart L, Vasquez-Soltero JM, Margolina A. <em>The human tri-peptide GHK and tissue remodeling.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18644225\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Maquart FX, et al. <em>Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu\u00b2\u207a.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/3169264\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Brcic L, et al. <em>Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20388964\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Chang CH, et al. <em>The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival and cell migration.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Philp D, et al. <em>Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in diabetic and aged mice.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12581423\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Philp D, et al. <em>The actin binding site on thymosin beta 4 promotes angiogenesis.<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><em>This article discusses published research for educational and scientific-reference purposes. The compounds described are intended for laboratory research and analytical use only and are not intended for human or veterinary use.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>GLOW Peptide Blend: GHK-Cu, BPC-157 and TB-500 Research The GLOW peptide blend combines three distinct research compounds: GHK-Cu, BPC-157 and TB-500 (Thymosin \u03b24). Each has been investigated separately in connection with tissue remodelling, cellular migration, extracellular-matrix biology and experimental repair processes. The name \u201cGLOW\u201d is a convenient commercial description rather than the name of a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1395","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/pages\/1395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/comments?post=1395"}],"version-history":[{"count":1,"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/pages\/1395\/revisions"}],"predecessor-version":[{"id":1396,"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/pages\/1395\/revisions\/1396"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/fr\/wp-json\/wp\/v2\/media?parent=1395"}],"curies":[{"name":"Bien jou\u00e9","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}